Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Peptide Synthesis Market: By Product & Service, By Reagents, By Equipment, By Technology, By End-user and Region Forecast 2019-2030
Peptide Synthesis Market size was valued at US$ 4,472.6 million in 2023 and is poised to grow at a significant CAGR of 7.7% from 2024- 2030. The concept of individualized therapy with the best response and largest safety margin to assure improved patient care has driven interest in personalized treatment. Proteomic analysis is a strong and appealing method for determining the molecular profiles of various tissues, whether healthy or sick. The next step in customized medicine is personalized proteomics, also known as proteome profiling, which clarifies illness path mechanisms.
Furthermore, Label-free sensors based on nanomaterials will then detect and quantify the ligand-receptor complexes. The technology will allow for the automated injection of the various reagents required for ligand synthesis, personalized and controlled peptide synthesis, and the use of proteomics in personalized medicine. The rising need for sophisticated treatments with few side effects and the increasing prevalence of diseases like cancer and cardiovascular disease drive more investment in customized therapy. Personalized medicine has the potential to improve healthcare while reducing costs. Players in the market will benefit from such advancements in personalized medicine. Using peptides in the pharmaceutical and consumer healthcare industries is driving the market's expansion. The peptides have many uses in treating malignancies, diabetes, and obesity, among other lifestyle problems. The rising prevalence of these metabolic and lifestyle diseases is opening the path for peptide therapies to be used in oncology and metabolic illnesses.
According to a report published by the International Diabetes Federation in 2020, around 463 million individuals were living with diabetes in 2019, with the prevalence expected to reach 700 million by 2045. The key reason driving the need for Custom Peptide Synthesis Services is increased research and development by biotechnology and pharmaceutical businesses. The lack of time available to scientists and researchers to create their customized peptides may drive the Custom market forward. Major peptide synthesis market companies may partner with smaller players to grow their market presence and raise revenue shares.
Study Period
2024-2030Base Year
2023CAGR
7.7%Largest Market
Asia PacificFastest Growing Market
North America
Peptides are pharmacological compounds that are both highly active and very selective. They are used in a wide range of therapeutic areas due to the diversity of their biological actions. Because of their broad chemical space, high physical activity, high specificity, relative simplicity of synthesis, accessible availability, and low toxicity, peptides are increasingly considered potential active pharmacological components in medication development. Peptides contribute billions of dollars in income in three major therapeutic areas: oncology, diabetes, and obesity. The use of peptides in treating cardiovascular and neurological illnesses, renal failure, and uncommon diseases is also rising. On the other hand, the lack of a unified set of regulations for therapeutic peptides hinders the market growth.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 4,472.6 million |
Market CAGR |
7.7% |
By Product & Service |
|
By Reagents |
|
By Equipment |
|
By Technology |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global peptide synthesis market size was valued at US$ 4,472.6 million in 2023 and is poised to grow at a significant CAGR of 7.7% from 2024- 2030.
Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, MP Biomedicals, Novo Nordisk A/S.
Europe is the fastest-growing region for the market
1.Executive Summary |
2.Global Peptide Synthesis Market Introduction |
2.1.Global Peptide Synthesis Market - Taxonomy |
2.2.Global Peptide Synthesis Market - Definitions |
2.2.1.Product & Service |
2.2.2.Reagents |
2.2.3.Equipment |
2.2.4.Technology |
2.2.5.Region |
3.Global Peptide Synthesis Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Peptide Synthesis Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Peptide Synthesis Market By Product & Service, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Reagents |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Equipment |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Services |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Peptide Synthesis Market By Reagents, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Resins |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Amino acids |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Coupling Reagents |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Dyes and Fluorescent labeling reagents |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Other Reagents |
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Peptide Synthesis Market By Equipment, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Peptide Synthesizers |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Chromatography Equipment |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Lyophiizers |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Peptide Synthesis Market By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Solid-Phase Peptide Synthesis |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Solution-Phase Peptide Synthesis |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Hybrid & Recombinant Technology |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Solution-Phase Peptide Synthesis |
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9.Global Peptide Synthesis Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Peptide Synthesis Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Product & Service Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Reagents |
10.1.2.Equipment |
10.1.3.Services |
10.2. Reagents Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Resins |
10.2.2.Amino acids |
10.2.3.Coupling Reagents |
10.2.4.Dyes and Fluorescent labeling reagents |
10.2.5.Other Reagents |
10.3. Equipment Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Peptide Synthesizers |
10.3.2.Chromatography Equipment |
10.3.3.Lyophiizers |
10.4. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Solid-Phase Peptide Synthesis |
10.4.2.Solution-Phase Peptide Synthesis |
10.4.3.Hybrid & Recombinant Technology |
10.4.4.Solution-Phase Peptide Synthesis |
10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Peptide Synthesis Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Reagents |
11.1.2.Equipment |
11.1.3.Services |
11.2. Reagents Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Resins |
11.2.2.Amino acids |
11.2.3.Coupling Reagents |
11.2.4.Dyes and Fluorescent labeling reagents |
11.2.5.Other Reagents |
11.3. Equipment Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Peptide Synthesizers |
11.3.2.Chromatography Equipment |
11.3.3.Lyophiizers |
11.4. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Solid-Phase Peptide Synthesis |
11.4.2.Solution-Phase Peptide Synthesis |
11.4.3.Hybrid & Recombinant Technology |
11.4.4.Solution-Phase Peptide Synthesis |
11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Peptide Synthesis Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Reagents |
12.1.2.Equipment |
12.1.3.Services |
12.2. Reagents Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Resins |
12.2.2.Amino acids |
12.2.3.Coupling Reagents |
12.2.4.Dyes and Fluorescent labeling reagents |
12.2.5.Other Reagents |
12.3. Equipment Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Peptide Synthesizers |
12.3.2.Chromatography Equipment |
12.3.3.Lyophiizers |
12.4. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Solid-Phase Peptide Synthesis |
12.4.2.Solution-Phase Peptide Synthesis |
12.4.3.Hybrid & Recombinant Technology |
12.4.4.Solution-Phase Peptide Synthesis |
12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Peptide Synthesis Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Reagents |
13.1.2.Equipment |
13.1.3.Services |
13.2. Reagents Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Resins |
13.2.2.Amino acids |
13.2.3.Coupling Reagents |
13.2.4.Dyes and Fluorescent labeling reagents |
13.2.5.Other Reagents |
13.3. Equipment Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Peptide Synthesizers |
13.3.2.Chromatography Equipment |
13.3.3.Lyophiizers |
13.4. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Solid-Phase Peptide Synthesis |
13.4.2.Solution-Phase Peptide Synthesis |
13.4.3.Hybrid & Recombinant Technology |
13.4.4.Solution-Phase Peptide Synthesis |
13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Peptide Synthesis Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
14.1. Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Reagents |
14.1.2.Equipment |
14.1.3.Services |
14.2. Reagents Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Resins |
14.2.2.Amino acids |
14.2.3.Coupling Reagents |
14.2.4.Dyes and Fluorescent labeling reagents |
14.2.5.Other Reagents |
14.3. Equipment Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Peptide Synthesizers |
14.3.2.Chromatography Equipment |
14.3.3.Lyophiizers |
14.4. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Solid-Phase Peptide Synthesis |
14.4.2.Solution-Phase Peptide Synthesis |
14.4.3.Hybrid & Recombinant Technology |
14.4.4.Solution-Phase Peptide Synthesis |
14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Genscript Biotech |
15.2.2.Merck KGaA |
15.2.3.Bachem Holdings |
15.2.4.Biotage |
15.2.5.CEM Corporation |
15.2.6.Thermo Fisher |
15.2.7.Creative Diagnostics |
15.2.8.Polypeptide Group |
15.2.9.Syngene |
15.2.10.PuroSynth |
15.2.11.Lonza |
15.2.12.MP Biomedicals |
15.2.13.Novo Nordisk A/S. |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players